Published in Blood Weekly, February 17th, 2005
According to recent research from South Korea, "hepatitis B virus (HBV) prophylaxis is necessary to prevent de novo hepatitis B infection from hepatitis B core antibody (HBcAb)-positive donors. However, which protocol is more effective is somewhat controversial. Also, it is uncertain whether it is necessary to administer HBV prophylaxis for hepatitis B surface antibody (HBsAb)-positive recipients."
"This study attempted to determine whether it is necessary to administer HBV prophylaxis for HBsAb-positive patients and to evaluate the efficacy of an hepatitis B immune...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.